The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Investigational drug

Sponsor

Merck Sharp & Dohme LLC